Welcome to LookChem.com Sign In|Join Free

CAS

  • or

6922-90-3

Post Buying Request

6922-90-3 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

6922-90-3 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 6922-90-3 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 6,9,2 and 2 respectively; the second part has 2 digits, 9 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 6922-90:
(6*6)+(5*9)+(4*2)+(3*2)+(2*9)+(1*0)=113
113 % 10 = 3
So 6922-90-3 is a valid CAS Registry Number.

6922-90-3Relevant articles and documents

I-Pr2NMgCl·LiCl Enables the Synthesis of Ketones by Direct Addition of Grignard Reagents to Carboxylate Anions

Colas, Kilian,Dos Santos, A. Catarina V. D.,Mendoza, Abraham

supporting information, (2019/10/08)

The direct preparation of ketones from carboxylate anions is greatly limited by the required use of organolithium reagents or activated acyl sources that need to be independently prepared. Herein, a specific magnesium amide additive is used to activate and control the addition of more tolerant Grignard reagents to carboxylate anions. This strategy enables the modular synthesis of ketones from CO2 and the preparation of isotopically labeled pharmaceutical building blocks in a single operation.

Triphenylbutanamines: Kinesin spindle protein inhibitors with in vivo antitumor activity

Wang, Fang,Good, James A. D.,Rath, Oliver,Kaan, Hung Yi Kristal,Sutcliffe, Oliver B.,MacKay, Simon P.,Kozielski, Frank

supporting information; experimental part, p. 1511 - 1525 (2012/04/10)

The human mitotic kinesin Eg5 represents a novel mitotic spindle target for cancer chemotherapy. We previously identified S-trityl-l-cysteine (STLC) and related analogues as selective potent inhibitors of Eg5. We herein report on the development of a series of 4,4,4-triphenylbutan-1-amine inhibitors derived from the STLC scaffold. This new generation systematically improves on potency: the most potent C-trityl analogues exhibit Kiapp ≥ 10 nM and GI50 ≈ 50 nM, comparable to results from the phase II clinical benchmark ispinesib. Crystallographic studies reveal that they adopt the same overall binding configuration as S-trityl analogues at an allosteric site formed by loop L5 of Eg5. Evaluation of their druglike properties reveals favorable profiles for future development and, in the clinical candidate ispinesib, moderate hERG and CYP inhibition. One triphenylbutanamine analogue and ispinesib possess very good bioavailability (51% and 45%, respectively), with the former showing in vivo antitumor growth activity in nude mice xenograft studies.

Directed Metalation of Benzenesulfinamides. A Novel Route to Meta-Substituted Aromatic Compounds

Katritzky, Alan R.,Lue, Ping

, p. 74 - 78 (2007/10/02)

Directed lithiation ortho to the sulfinamide group of readily available ortho- and para-substituted N-phenylbenzenesulfinamides (5a-d) and reaction with a variety of electrophiles followed by mercuridesulfination (HgCl2) or dehydrodesulfination (Ra/Ni) co

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 6922-90-3